Surg: Prostate Cancer: Free MSRA Podcast

🎧 Deep Dive: Prostate Cancer – High-Yield MSRA Surgery RevisionWelcome to this focused MSRA Deep Dive on Prostate Cancer – one of the most important and commonly tested topics in men’s health. We’ll simplify the essential facts, boost your recall, and guide your revision with memory tips, mnemonics, and clinical insights.🔬 What is Prostate Cancer?A malignant tumour of the prostate gland, usually an adenocarcinoma, starting in glandular cells.🧠 Key terms: Malignant • Abnormal growth • Glandular origin • Peripheral zone🧬 Causes & Risk FactorsAge >50Family historyBlack ethnicityBRCA1/BRCA2 mutationsObesity💡 Mnemonic: AFB-U (Age, Family, BRCA, Unhealthy weight)📉 PathophysiologyUncontrolled cell growth → local invasion + metastasisSpreads to bone and lymph nodes95% = adenocarcinomasVariable progression: indolent vs aggressive⚖️ Differential DiagnosesBPH (benign enlargement)ProstatitisUTIBladder/kidney stonesBladder cancer📊 Epidemiology (UK)Most common cancer in men~1 in 8 lifetime risk~52,300 new cases/yearPeak: 75–79 yrsMore common in Black men, less in Asian men🚨 SymptomsOften asymptomatic early onLUTS: weak stream, frequency, urgency, nocturiaHematuria, hematospermia, erectile dysfunctionBone pain, weight loss in advanced diseaseDRE: hard, irregular, nodular prostate🧪 InvestigationsPSA (screening tool, not diagnostic)DREMultiparametric MRI (first-line per NICE)Biopsy (TRUS-guided – gold standard)Bone scan – if metastasis suspectedStaging: TNM systemGrading: Gleason score or ISUP grade • Gleason = 6 (low), 7 (intermediate), 8–10 (high)🛠 Management🟢 Low-risk: active surveillance🟡 Localised: surgery (radical prostatectomy) or radiotherapy🔴 Advanced/metastatic: • Androgen deprivation therapy (ADT) • ± chemo (e.g., docetaxel), newer anti-androgens (e.g., enzalutamide) • ± targeted therapy (e.g., olaparib if BRCA+) • Palliative care for symptoms (bone pain, spinal mets)⚠️ ComplicationsMetastasis (esp. bone, spine → cord compression)Urinary incontinence, erectile dysfunctionADT side effects: hot flushes, fatigue, bone lossObstruction, fractures, psychosocial impact📈 PrognosisLocalised: high cure ratesMetastatic: not curable, but treatable2nd most common cause of cancer death in UK menEarly detection = better outcomes🧠 MSRA FocusKnow:✔️ PSA + DRE roles✔️ Gleason/ISUP grading✔️ Risk stratification✔️ ADT in metastatic disease✔️ LUTS differentials (BPH, prostatitis)📚 MSRA Study Resources – Prostate Cancer📝 Revision Notes:https://www.passthemsra.com/topic/prostate-cancer-revision-notes/🧠 Flashcards:https://www.passthemsra.com/topic/prostate-cancer-flashcards/❓ Q&A Notes:https://www.passthemsra.com/topic/prostate-cancer-accordion-qa-notes/🔥 Rapid Quiz:https://www.passthemsra.com/topic/prostate-cancer-rapid-quiz/🧪 Quiz Bank:https://www.passthemsra.com/quizzes/prostate-cancer/💬 Final ThoughtSilent early stages + serious late complications = why early detection matters.For more high-yield tools, visit:🌐 https://passthemsra.com🌐 https://freemsra.com